Pediatrix Medical Group Statistics
Total Valuation
MD has a market cap or net worth of $1.83 billion. The enterprise value is $1.99 billion.
Important Dates
The last earnings date was Tuesday, May 5, 2026, before market open.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MD has 81.14 million shares outstanding. The number of shares has increased by 1.14% in one year.
| Current Share Class | 81.14M |
| Shares Outstanding | 81.14M |
| Shares Change (YoY) | +1.14% |
| Shares Change (QoQ) | -1.59% |
| Owned by Insiders (%) | 1.32% |
| Owned by Institutions (%) | 105.41% |
| Float | 80.02M |
Valuation Ratios
The trailing PE ratio is 11.00 and the forward PE ratio is 10.11.
| PE Ratio | 11.00 |
| Forward PE | 10.11 |
| PS Ratio | 0.87 |
| Forward PS | 0.84 |
| PB Ratio | 1.97 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 11.43 |
| EV / Sales | 1.03 |
| EV / EBITDA | 7.63 |
| EV / EBIT | 8.33 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.48, with a Debt / Equity ratio of 0.72.
| Current Ratio | 2.48 |
| Quick Ratio | 2.34 |
| Debt / Equity | 0.72 |
| Debt / EBITDA | 2.29 |
| Debt / FCF | n/a |
| Interest Coverage | 6.81 |
Financial Efficiency
Return on equity (ROE) is 20.89% and return on invested capital (ROIC) is 16.81%.
| Return on Equity (ROE) | 20.89% |
| Return on Assets (ROA) | 7.35% |
| Return on Invested Capital (ROIC) | 16.81% |
| Return on Capital Employed (ROCE) | 13.03% |
| Weighted Average Cost of Capital (WACC) | 7.09% |
| Revenue Per Employee | $451,329 |
| Profits Per Employee | $40,706 |
| Employee Count | 4,280 |
| Asset Turnover | 0.95 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MD has paid $52.96 million in taxes.
| Income Tax | 52.96M |
| Effective Tax Rate | 23.31% |
Stock Price Statistics
The stock price has increased by +66.18% in the last 52 weeks. The beta is 0.71, so MD's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | +66.18% |
| 50-Day Moving Average | 21.12 |
| 200-Day Moving Average | 19.55 |
| Relative Strength Index (RSI) | 45.85 |
| Average Volume (20 Days) | 673,248 |
Short Selling Information
The latest short interest is 3.46 million, so 4.26% of the outstanding shares have been sold short.
| Short Interest | 3.46M |
| Short Previous Month | 3.04M |
| Short % of Shares Out | 4.26% |
| Short % of Float | 4.32% |
| Short Ratio (days to cover) | 3.99 |
Income Statement
In the last 12 months, MD had revenue of $1.93 billion and earned $174.22 million in profits. Earnings per share was $2.06.
| Revenue | 1.93B |
| Gross Profit | 504.03M |
| Operating Income | 238.96M |
| Pretax Income | 227.19M |
| Net Income | 174.22M |
| EBITDA | 260.91M |
| EBIT | 238.96M |
| Earnings Per Share (EPS) | $2.06 |
Full Income StatementBalance Sheet
The company has $328.97 million in cash and $629.72 million in debt, with a net cash position of -$300.74 million or -$3.71 per share.
| Cash & Cash Equivalents | 328.97M |
| Total Debt | 629.72M |
| Net Cash | -300.74M |
| Net Cash Per Share | -$3.71 |
| Equity (Book Value) | 878.58M |
| Book Value Per Share | 10.58 |
| Working Capital | 350.10M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 21.95M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 26.09%, with operating and profit margins of 12.37% and 9.02%.
| Gross Margin | 26.09% |
| Operating Margin | 12.37% |
| Pretax Margin | 11.76% |
| Profit Margin | 9.02% |
| EBITDA Margin | 13.51% |
| EBIT Margin | 12.37% |
| FCF Margin | n/a |
Dividends & Yields
MD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.14% |
| Shareholder Yield | -1.14% |
| Earnings Yield | 10.31% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for MD is $20.50, which is -8.89% lower than the current price. The consensus rating is "Hold".
| Price Target | $20.50 |
| Price Target Difference | -8.89% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 4.60% |
| EPS Growth Forecast (5Y) | 2.14% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on December 20, 2013. It was a forward split with a ratio of 2:1.
| Last Split Date | Dec 20, 2013 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |
